SHP-1 Regulates Antigen Cross-Presentation and Is Exploited by Leishmania to Evade Immunity

Intracellular pathogens have evolved strategies to evade detection by cytotoxic CD8+ T lymphocytes (CTLs). Here, we ask whether Leishmania parasites trigger the SHP-1-FcRγ chain inhibitory axis to dampen antigen cross-presentation in dendritic cells expressing the C-type lectin receptor Mincle. We f...

Full description

Saved in:
Bibliographic Details
Published inCell reports (Cambridge) Vol. 33; no. 9; p. 108468
Main Authors Khouili, Sofía C., Cook, Emma C.L., Hernández-García, Elena, Martínez-López, María, Conde-Garrosa, Ruth, Iborra, Salvador
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2020
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Intracellular pathogens have evolved strategies to evade detection by cytotoxic CD8+ T lymphocytes (CTLs). Here, we ask whether Leishmania parasites trigger the SHP-1-FcRγ chain inhibitory axis to dampen antigen cross-presentation in dendritic cells expressing the C-type lectin receptor Mincle. We find increased cross-priming of CTLs in Leishmania-infected mice deficient for Mincle or with a selective loss of SHP-1 in CD11c+ cells. The latter also shows improved cross-presentation of cell-associated viral antigens. CTL activation in vitro reveals increased MHC class I-peptide complex expression in Mincle- or SHP-1-deficient CD11c+ cells. Neuraminidase treatment also boosts cross-presentation, suggesting that Leishmania triggers SHP-1-associated sialic-acid-binding receptors. Mechanistically, enhanced antigen processing correlates with reduced endosomal acidification in the absence of SHP-1. Finally, we demonstrate that SHP-1 inhibition improves CD11c+ cell-based vaccination against the parasite. Thus, SHP-1-mediated impairment of cross-presentation can be exploited by pathogens to evade CTLs, and SHP-1 inhibition improves CTL responses during vaccination. [Display omitted] •Lack of Mincle or SHP-1 loss in CD11c+ cells raises CD8+ T cell priming to Leishmania•SHP-1 deficiency increases endosomal pH and enhances antigen cross-presentation•SHP-1 inhibition boosts CD11c+ cell-based vaccination efficacy against Leishmania Khouili et al. identify SHP-1 as a negative regulator of antigen cross-presentation that Leishmania can trigger by interacting with Mincle and sialic-acid-binding receptors, dampening early CD8+ T cell recognition. Loss of functional SHP-1 in CD11c+ cells decreases endosomal acidification, increases cross-presentation, and boosts CD11c+ cell-based vaccination against Leishmania.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2211-1247
2211-1247
DOI:10.1016/j.celrep.2020.108468